Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Fetal skin has unique immune cells different from adult skin.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Regulatory T cells enhance bone formation by influencing cell mechanics.